These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25611474)

  • 1. Strategies to reduce risks in ARV supply chains in the developing world.
    Larson C; Burn R; Minnick-Sakal A; Douglas MO; Kuritsky J
    Glob Health Sci Pract; 2014 Dec; 2(4):395-402. PubMed ID: 25611474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patents versus patients? Antiretroviral therapy in India.
    Havlir DV; Hammer SM
    N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
    [No Abstract]   [Full Text] [Related]  

  • 3. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
    Jain D; Darrow JJ
    Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the generic antiretroviral industry support access to a universal antiretroviral regimen?
    Amole CD; Middlecote C; Prabhu VR; Kumarasamy N
    Curr Opin HIV AIDS; 2017 Jul; 12(4):390-397. PubMed ID: 28441147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Call for action to secure universal access to ART in developing countries.
    Orsi F; Carrieri MP; Coriat B; Delaporte E; Moatti JP; Spire B; Taverne B; Barré-Sinoussi F
    Lancet; 2010 May; 375(9727):1693-4. PubMed ID: 20472168
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic antiretroviral drugs--will they be the answer to HIV in the developing world?
    Kumarasamy N
    Lancet; 2004 Jul 3-9; 364(9428):3-4. PubMed ID: 15234833
    [No Abstract]   [Full Text] [Related]  

  • 7. USA announces plan to expedite AIDS drug approvals.
    Nelson R
    Lancet; 2004 May; 363(9423):1779. PubMed ID: 15174473
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.
    Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M
    JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinton brokers deal to lower price of antiretrovirals.
    Abimbola S
    BMJ; 2007 May; 334(7602):1026. PubMed ID: 17510129
    [No Abstract]   [Full Text] [Related]  

  • 11. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 12. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11785481
    [No Abstract]   [Full Text] [Related]  

  • 13. Working together to provide generics for health.
    Beck EJ; Reiss P
    Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring the safety of HIV/AIDS generics.
    Frost KR
    Lancet; 2005 Apr 9-15; 365(9467):1290-1. PubMed ID: 15823366
    [No Abstract]   [Full Text] [Related]  

  • 15. "3 by 5" should be replaced by "Free by 5".
    Bosch X
    Lancet Infect Dis; 2005 Feb; 5(2):76. PubMed ID: 15702506
    [No Abstract]   [Full Text] [Related]  

  • 16. What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Dionisio D; Gass R; McDermott P; Racalbuto V; Madeo M; Braghieri G; Crowley S; Pinheiro Edos S; Graaff P; Vasan A; Eksaengsri A; Moller H; Khanna AK; Kraisintu K; Juneja S; Nicolaou S; Sengupta A; Esperti F; Messeri D
    Curr HIV Res; 2007 Mar; 5(2):155-87. PubMed ID: 17346132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic and branded drugs for the treatment of people living with HIV/AIDS.
    Bartlett JA; Muro EP
    J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cheap HIV drugs for developing countries.
    Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
    [No Abstract]   [Full Text] [Related]  

  • 19. Realization of an AIDS-free generation: ensuring sustainable treatment for children.
    Heidari S; Mofenson LM; Bekker LG
    JAMA; 2014 Jul 23-30; 312(4):339-40. PubMed ID: 25038347
    [No Abstract]   [Full Text] [Related]  

  • 20. Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention.
    Gayle H; Lange JM
    Lancet; 2004 Jul 3-9; 364(9428):6-8. PubMed ID: 15234835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.